These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1123 related articles for article (PubMed ID: 8641998)

  • 21. AknT is an activating protein for the glycosyltransferase AknS in L-aminodeoxysugar transfer to the aglycone of aclacinomycin A.
    Lu W; Leimkuhler C; Gatto GJ; Kruger RG; Oberthür M; Kahne D; Walsh CT
    Chem Biol; 2005 May; 12(5):527-34. PubMed ID: 15911373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of aklavinone-11-hydroxylase from Streptomyces purpurascens.
    Niemi J; Wang Y; Airas K; Ylihonko K; Hakala J; Mäntsälä P
    Biochim Biophys Acta; 1999 Feb; 1430(1):57-64. PubMed ID: 10082933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of anthraquinones by interspecies cloning of actinorhodin biosynthesis genes in streptomycetes: clarification of actinorhodin gene functions.
    Bartel PL; Zhu CB; Lampel JS; Dosch DC; Connors NC; Strohl WR; Beale JM; Floss HG
    J Bacteriol; 1990 Sep; 172(9):4816-26. PubMed ID: 2394677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed Biosynthesis of Iso-aclacinomycins with Improved Anticancer Activity.
    Hu Y; Zhang Z; Yin Y; Tang GL
    Org Lett; 2020 Jan; 22(1):150-154. PubMed ID: 31829601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on the antitumor antibiotic aclacinomycin A].
    Zhang H; Wang D; Xu S; Ye Y; Chen P
    Wei Sheng Wu Xue Bao; 1991 Jun; 31(3):247-50. PubMed ID: 1862654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbial conversion of anthracycline antibiotics. I. Microbial conversion of aclacinomycin B to aclacinomycin A.
    Hoshino T; Sekine Y; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1458-62. PubMed ID: 6581152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthracycline antibiotic 2-hydroxyaclacinomycins. II. Production of 2-hydroxyaclacinomycins A and B by a new recombinant strain and their antitumor activities.
    Yoshimoto A; Johdo O; Ishikura T; Takeuchi T
    Jpn J Antibiot; 1991 Mar; 44(3):277-86. PubMed ID: 1880910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for substrate recognition and specificity in aklavinone-11-hydroxylase from rhodomycin biosynthesis.
    Lindqvist Y; Koskiniemi H; Jansson A; Sandalova T; Schnell R; Liu Z; Mäntsälä P; Niemi J; Schneider G
    J Mol Biol; 2009 Nov; 393(4):966-77. PubMed ID: 19744497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression, purification, and characterization of AknX anthrone oxygenase, which is involved in aklavinone biosynthesis in Streptomyces galilaeus.
    Chung JY; Fujii I; Harada S; Sankawa U; Ebizuka Y
    J Bacteriol; 2002 Nov; 184(22):6115-22. PubMed ID: 12399480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AknK is an L-2-deoxyfucosyltransferase in the biosynthesis of the anthracycline aclacinomycin A.
    Lu W; Leimkuhler C; Oberthür M; Kahne D; Walsh CT
    Biochemistry; 2004 Apr; 43(15):4548-58. PubMed ID: 15078101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid anthracyclines from a genetically engineered Streptomyces galilaeus mutant.
    Kunnari TJ; Ylihonko KP; Klika KD; Mäntsälä PI; Hakala JM
    J Org Chem; 2000 May; 65(10):2851-5. PubMed ID: 10814169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning of aklavinone biosynthesis genes from Streptomyces galilaeus.
    Tsukamoto N; Fujii I; Ebizuka Y; Sankawa U
    J Antibiot (Tokyo); 1992 Aug; 45(8):1286-94. PubMed ID: 1399850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer.
    Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production of a new hybrid anthracycline 4-O-methylepelmycin by heterologous expression of dnrK in epelmycin-producing Streptomyces violaceus.
    Miyamoto Y; Ohta S; Johdo O; Nagamatsu Y; Yoshimoto A
    J Antibiot (Tokyo); 2000 Aug; 53(8):828-36. PubMed ID: 11079805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crystal structure of aclacinomycin methylesterase with bound product analogues: implications for anthracycline recognition and mechanism.
    Jansson A; Niemi J; Mäntsälä P; Schneider G
    J Biol Chem; 2003 Oct; 278(40):39006-13. PubMed ID: 12878604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New anthracycline antibiotics.
    Oki T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():70-84. PubMed ID: 612711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intra- and interspecific cosynthetic activity of mutants of Streptomyces coeruleorubidus and Streptomyces galilaeus impaired in the biosynthesis of anthracyclines.
    Blumauerová M; Královocová E; Hostálek Z; Vanĕk Z
    Folia Microbiol (Praha); 1979; 24(2):128-35. PubMed ID: 456947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure by NMR of antitumor drugs aclacinomycin A and B complexed to d(CGTACG).
    Yang D; Wang AH
    Biochemistry; 1994 May; 33(21):6595-604. PubMed ID: 8204596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of aklavinone and aclacinomycins.
    Kitamura I; Tobe H; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1981 Nov; 34(11):1498-500. PubMed ID: 7319911
    [No Abstract]   [Full Text] [Related]  

  • 40. Further examination of 9-alkyl- and sugar-modified anthracyclines in the circumvention of multidrug resistance.
    Coley HM; Twentyman PR; Workman P
    Anticancer Drug Des; 1992 Dec; 7(6):471-81. PubMed ID: 1337431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.